About this trial
The purpose of this study was to investigate the efficacy and safety of repairing facial mask containing Asiaticum asiatica in treating disjunctive skin diseases. A multi-center randomized double-blind self-half face control method was used. A computer-generated randomization method was used. Each cheek was randomly assigned to receive the snow glycoside mask and the control group.
Eligibility criteria
Qualifiers
Meet mild to moderate rosacea, acne diagnostic criteria; Meet the diagnostic criteria for melasma;
Over 18 years of age;
Be able to follow the treatment rules of the study and be followed for 8 weeks;
Informed consent; 5There were no significant cardiac, liver, kidney, gastrointestinal, neurological, psychiatric, or metabolic disorders
Disqualifiers
Currently pregnant, planning to become pregnant or breastfeeding;
Documented hypersensitivity to any active ingredient or excipient included in the study drug, or a history of adverse reactions to cosmetic products;
Participate in other clinical studies within 3 months before the start of the study;
Frequent use of Chinese medicine, sleeping pills, sedatives, anti-anxiety drugs or potentially addictive substances;
Trial design
Treatments tested in this trial
- Face mask containing Centella sinensis